Clinical Trials on Lung Cancer, Non-small Cell in United Kingdom
Total 10131 results
-
Aptium Oncology Research NetworkMillennium Pharmaceuticals, Inc.UnknownNon-small Cell Lung CancerUnited States
-
Gilead SciencesMerck Sharp & Dohme LLCActive, not recruitingNon-small Cell Lung CancerUnited States, Spain, Italy, France, Australia, Hong Kong, Korea, Republic of, Malaysia, Taiwan, Germany, United Kingdom, Canada
-
US Oncology ResearchPfizerCompleted
-
Diwakar DavarGateway for Cancer ResearchNot yet recruitingNon Small Cell Lung CancerUnited States
-
Abramson Cancer Center at Penn MedicineRecruiting
-
Fox Chase Cancer CenterCompletedNon Small Cell Lung CancerUnited States
-
Ethicon Endo-SurgeryCompletedNon Small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)TerminatedExtensive Stage Small Cell Lung Cancer | Recurrent Small Cell Lung Cancer | Stage IV Colon Cancer | Stage IV Rectal Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
AbelZeta, Inc.Nektar TherapeuticsRecruiting
-
Washington University School of MedicineApollomics Inc.RecruitingMetastatic Non Small Cell Lung CancerUnited States
-
Albert Einstein College of MedicineCelldex TherapeuticsActive, not recruitingNon-small Cell Lung Cancer (NSCLC)United States
-
West Virginia UniversityWest Virginia Clinical and Translational Science InstituteCompletedNon Small Cell Lung Cancer MetastaticUnited States
-
Lyudmila Bazhenova, M.D.BeyondSpring Pharmaceuticals Inc.Active, not recruitingNon-small Cell Lung Cancer MetastaticUnited States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedStage IV Non-small Cell Lung CancerUnited States
-
University of Michigan Rogel Cancer CenterTerminatedAdvanced Non-Small Cell Lung CancerUnited States
-
The Cooper Health SystemUnknownUntreated Advanced Non-Small Cell Lung CancerUnited States
-
OncoC4, Inc.BioNTech SERecruitingONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors (PRESERVE-003)Non Small Cell Lung CancerUnited States, Belgium, Canada, France, Germany, Italy, Spain, China, Korea, Republic of, Netherlands, Turkey, United Kingdom, Australia
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerIndia, Turkey, China, United States, Germany, Spain, Taiwan, Belgium, Korea, Republic of, France, Greece, Netherlands, United Kingdom, Australia, Canada, Brazil, Ireland, Portugal, Argentina
-
Daiichi Sankyo, Inc.ArQule, Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary...TerminatedNon Squamous, Non-small-cell Lung CancerPoland, France, Germany, Italy, Spain, Canada, United States, Argentina, Belgium, Mexico, Australia, Russian Federation, Netherlands, Peru, Brazil, Austria, United Kingdom, Sweden, Czechia, Chile, Denmark, Hungary, Romania
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerSpain, Taiwan, Japan, United States, France, Germany, Korea, Republic of, Malaysia
-
Greg Durm, MDMerck Sharp & Dohme LLC; Big Ten Cancer Research ConsortiumCompleted
-
Jennifer BellEmory University; University of Virginia; University of North CarolinaCompletedNon-small Cell Lung CancerUnited States
-
University of Maryland, BaltimoreTragara Pharmaceuticals, Inc.CompletedLung Cancer | Non Small Cell Lung CancerUnited States
-
YM BioSciencesCIMYM BioSciencesTerminatedNon-small-cell Lung CancerCanada, United States, Singapore
-
Symphony Evolution, Inc.TerminatedNon-Small-Cell Lung CancerUnited States
-
Bristol-Myers SquibbCompletedNon-small Cell Lung CancerUnited States, Canada
-
Indiana UniversityNational Institute of General Medical Sciences (NIGMS)RecruitingMelanoma | Non Small Cell Lung CancerUnited States
-
Thomas MarronRecruiting
-
Johns Hopkins UniversityAstraZenecaEnrolling by invitationNon-small Cell Lung Cancer (NSCLC)United States
-
Abramson Cancer Center of the University of PennsylvaniaTerminatedNon-Small Cell Lung Cancer (NSCLC)United States
-
Fox Chase Cancer CenterTerminatedNon Small Cell Lung Cancer Stage IIIBUnited States
-
Massachusetts General HospitalBoehringer Ingelheim; University of TexasCompletedNon-small Cell Lung Cancer | EGFR MutationsUnited States
-
Lucence Health Inc.Active, not recruitingNon Small Cell Lung CancerUnited States
-
M.D. Anderson Cancer CenterConquer Cancer FoundationActive, not recruitingNon-small Cell Lung CancerUnited States
-
Massachusetts General HospitalCompletedNon Small Cell Lung CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Malignant Pleural EffusionUnited States
-
RedCloud BioParexelRecruitingNon-small Cell Lung CancerUnited States
-
Muhammad FurqanBiodesix, Inc.TerminatedNon Small Cell Lung CancerUnited States
-
Addario Lung Cancer Medical InstituteWithdrawn
-
University of California, DavisNovartis PharmaceuticalsCompletedSolid Tumors | Non-Small Cell Lung Cancer (NSCLC)United States
-
Integrated Community Oncology NetworkSanofiUnknownPreviously Treated Metastatic Non-Small Cell Lung CancerUnited States
-
University of Texas Southwestern Medical CenterAstraZenecaActive, not recruitingNon-small Cell Lung Cancer (NSCLC)United States
-
Liza Villaruz, MDGenentech, Inc.CompletedAdvanced Non-small Cell Lung CancerUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedStage IV Non-Small Cell Lung CancerUnited States
-
AVAX TechnologiesTerminatedNon-Small Cell Lung Cancer - Completely ResectableUnited States
-
University of Kansas Medical CenterRecruitingNon Small Cell Lung Cancer StageUnited States
-
AbbVieCompletedNon-squamous Non-small Cell Lung CancerUnited States, Argentina, Australia, Canada, Czechia, Denmark, Finland, Germany, Hungary, Israel, Japan, Korea, Republic of, Netherlands, New Zealand, Russian Federation, South Africa, Spain, Taiwan, Turkey, United Kingdom
-
Novartis PharmaceuticalsCompletedNon-small Cell Lung CancerFrance, Italy, United Kingdom, Hungary, Belgium, Canada, Spain, Germany, Singapore, Netherlands, Thailand, United States, Turkey, Argentina, Brazil, Hong Kong, Japan, Taiwan
-
Duke UniversityEli Lilly and CompanyTerminatedNon Small Cell Lung CancerUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)TerminatedRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | EGFR Activating MutationUnited States